Ignite Creation Date:
2024-05-06 @ 6:38 PM
Last Modification Date:
2024-10-26 @ 2:52 PM
Study NCT ID:
NCT05738317
Status:
RECRUITING
Last Update Posted:
2023-02-22
First Post:
2023-02-12
Brief Title:
Adebrelimab Combined With Bevacizumab and Albumin Paclitaxel in Non-squamous NSCLC After First-line Treatment
Sponsor:
Organization:
Wuhan Union Hospital China